sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
OCUL
Updated 10/6/2026, 11:12 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| OCUL OCULAR THERAPEUTIX, INC | Sale | $11,254 | Notman Donald Chief Operating Officer | 1,099 sh | at $10.24 | Filed Sep 2, 4:01 PM ET | Filing | |
| OCUL OCULAR THERAPEUTIX, INC | Sale | $32,687 | Kaiser Peter Chief Development Officer | 3,035 sh | at $10.77 | Filed Aug 26, 5:59 PM ET | Filing | |
| OCUL OCULAR THERAPEUTIX, INC | Sale | $20,450 | Nayak Sanjay Chief Strategy Officer | 1,897 sh | at $10.78 | Filed Aug 26, 5:58 PM ET | Filing | |
| OCUL OCULAR THERAPEUTIX, INC | Sale | $35,531 | Heier Jeffrey S. Chief Scientific Officer | 3,296 sh | at $10.78 | Filed Aug 26, 5:57 PM ET | Filing | |
| OCUL OCULAR THERAPEUTIX, INC | Sale | $233,160 | Dugel Pravin See Remarks, Director | 21,649 sh | at $10.77 | Filed Aug 26, 5:56 PM ET | Filing |